Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 03/09/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 02/17/22 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
12 | ||
| 01/25/22 | Current report filing |
|
 |
6 | |
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/04/22 | Statement of changes in beneficial ownership of securities |
|
1 |